Mardon McFarlane is an Associate Director in the External Manufacturing group at CRISPR Therapeutics and is responsible for the relationship management and overall governance of an external global network of CDMOs (contract development & manufacturing organisations). In this role he ensures the delivery of drug products to support CRISPR Therapeutic’s clinical portfolio. He has over 16 years’ experience in the biotechnology sector with over half of those years being in the cutting-edge sector of cell and gene therapy. Mardon’s career has been focused on the processing aspects of drug manufacture and has spanned process development, technology transfer & scale up and large-scale manufacturing. Mardon holds an MEng in Biochemical Engineering from University College London.